Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS: NWBO · Delayed Price · USD
0.388
0.00 (0.08%)
Jul 19, 2024, 4:00 PM EDT - Market closed

Northwest Biotherapeutics Market Cap

Northwest Biotherapeutics has a market cap or net worth of $469.22 million as of July 22, 2024. Its market cap has decreased by -20.49% in one year.

Market Cap
469.22M
Enterprise Value
515.82M
1-Year Change
-20.49%
Ranking
n/a
Category
Stock Price
$0.39

Market Cap Chart

Since December 31, 2001, Northwest Biotherapeutics's market cap has increased from $84.90M to $469.22M, an increase of 452.67%. That is a compound annual growth rate of 7.87%.

History

DateMarket Cap% Change
Jul 19, 2024467.60M-42.19%
Dec 29, 2023808.80M-2.01%
Dec 30, 2022825.40M27.10%
Dec 31, 2021649.40M-41.78%
Dec 31, 20201.12B789.55%
Dec 31, 2019125.40M17.97%
Dec 31, 2018106.30M40.24%
Dec 29, 201775.80M75.06%
Dec 30, 201643.30M-85.35%
Dec 31, 2015295.50M-11.23%
Dec 31, 2014332.90M129.27%
Dec 31, 2013145.20M88.08%
Dec 31, 201277.20M110.93%
Dec 30, 201136.60M-34.76%
Dec 31, 201056.10M22.22%
Dec 31, 200945.90M237.50%
Dec 31, 200813.60M-87.36%
Dec 31, 2007107.60M2,239.13%
Dec 29, 20064.60M142.11%
Dec 30, 20051.90M137.50%
Dec 31, 2004800.00K-80.95%
Dec 31, 20034.20M55.56%
Dec 31, 20022.70M-96.82%
Dec 31, 200184.90M-
View and export this data all the way back to 2001. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 814.94B
Novo Nordisk 579.91B
UnitedHealth Group 520.32B
Johnson & Johnson 372.29B
Merck & Co. 318.55B
AbbVie 304.29B
AstraZeneca 244.04B
Novartis AG 207.64B
Market Cap Rankings